Literature DB >> 24709082

Reply: anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series.

Giacomo Emmi1, Elena Silvestri, Lucia Ciucciarelli, Danilo Squatrito, Lorenzo Emmi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24709082

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  4 in total

1.  Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study.

Authors:  Giacomo Emmi; Rosaria Talarico; Giuseppe Lopalco; Rolando Cimaz; Fabrizio Cantini; Ombretta Viapiana; Ignazio Olivieri; Matteo Goldoni; Antonio Vitale; Elena Silvestri; Domenico Prisco; Giovanni Lapadula; Mauro Galeazzi; Florenzo Iannone; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-07-10       Impact factor: 2.980

Review 2.  Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.

Authors:  Jurgen Sota; Donato Rigante; Giuseppe Lopalco; Bruno Frediani; Rossella Franceschini; Mauro Galeazzi; Florenzo Iannone; Gian Marco Tosi; Claudia Fabiani; Luca Cantarini
Journal:  Rheumatol Int       Date:  2017-07-27       Impact factor: 2.631

Review 3.  The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases.

Authors:  Claudia Fabiani; Jurgen Sota; Gian Marco Tosi; Rossella Franceschini; Bruno Frediani; Mauro Galeazzi; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2016-12-28       Impact factor: 2.980

4.  Behçet's syndrome: focus on pathogenetic background, clinical phenotypes and specific treatments.

Authors:  Giacomo Emmi; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2019-07-17       Impact factor: 3.397
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.